nafamostat has been researched along with Hemophilia A in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Hemophilia A: The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Therefore, hemodialysis using an arteriovenous fistula was induced for renal replacement therapy." | 1.56 | Induction of hemodialysis with an arteriovenous fistula in a patient with hemophilia A. ( Aomatsu, A; Hirai, K; Hoshino, T; Ishii, H; Ito, K; Kaku, Y; Kaneko, S; Kitano, T; Matsuyama, M; Minato, S; Miyazawa, H; Miyoshi, C; Morino, J; Morishita, Y; Ookawara, S; Shimoyama, H; Shindo, M; Ueda, Y; Yanai, K, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, H | 1 |
| Miyoshi, C | 1 |
| Hirai, K | 1 |
| Morino, J | 1 |
| Minato, S | 1 |
| Kaneko, S | 1 |
| Yanai, K | 1 |
| Matsuyama, M | 1 |
| Kitano, T | 1 |
| Shindo, M | 1 |
| Aomatsu, A | 1 |
| Shimoyama, H | 1 |
| Miyazawa, H | 1 |
| Ito, K | 1 |
| Ueda, Y | 1 |
| Kaku, Y | 1 |
| Hoshino, T | 1 |
| Ookawara, S | 1 |
| Morishita, Y | 1 |
1 other study available for nafamostat and Hemophilia A
| Article | Year |
|---|---|
Induction of hemodialysis with an arteriovenous fistula in a patient with hemophilia A.
Topics: Aged, 80 and over; Anticoagulants; Arteriovenous Fistula; Benzamidines; Coagulants; Factor VIII; Gua | 2020 |